Document is current
Any future updates will be listed below
-
Authors
Dammann-Bawadkji, Inga https://orcid.org/0000-0002-5878-4149
Leweke, F. Markus https://orcid.org/0000-0002-8163-195X
Rohleder, Cathrin https://orcid.org/0000-0002-3559-1846
-
Funding
Funding for this research was provided by:
The University of Sydney
- License Information
-
More Information
Article History
Accepted: 1 June 2026
First Online: 14 July 2026
Declarations
:
: F.M.L. is a shareholder of curantis UG (Ltd.). C.R. is a shareholder of lero bioscience UG (Ltd.). I.D.-B., F.M.L. and C.R. are full or part-time employees of Endosane ® Pharmaceuticals GmbH. F.M.L. received an Investigator Initiated Trial Grant from Endosane ® Pharmaceuticals GmbH. All authors declare that they have no conflicts of interest with the contents of this article and that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: Not applicable; this article did not involve research on any human participants or animals.
: Not applicable; no new human data were created or analyzed for this article.
: Not applicable; this article does not present human data.
: Not applicable; no new human or animal data were created or analyzed for this article.
: Not applicable; no data were analyzed using a code for this article.
: All authors contributed to the manuscript conception and design. The first draft of the manuscript was written by I.D.-B., and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript and agree to be accountable for all aspects of the work.
